A Study to Evaluate Voice-enabled Artificial Intelligence to Diagnosis Hepatic Encephalopathy

Overview

About this study

early detection of hepatic encephalopathy

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Male or female, age ≥ 18 years old.
  • Having hepatic encephalopathy (HE).
  • Are in the hospital (Methodist or St. Marys). Consented in an exam room or hospital room
  • Must be able to carry on a conversation.
  • Ability of subject or caregiver to provide written, informed consent. (LAR needed if subject is HE)
  • Cirrhosis of any etiology.

Exclusion Criteria:

  • Individual < 18 years old.
  • Known history of voice disorder or surgery that may alter voice characteristics.
  • Smoking or vaping use currently or within the last 3 months
  • Severe chronic obstructive pulmonary disease
  • Inability to speak.
  • Upper respiratory tract infection within the last week.
  • Acute alcohol intoxication.
  • VHI-10 score greater than 11.
  • West Haven Criteria Grade 4.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Douglas Simonetto, M.D.

Open for enrollment

Contact information:

M Felmlee Devine M.S., CCRP

FelmleeDevine.Donna@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20510474

Mayo Clinic Footer